Table of Content

1 INTRODUCTION 
    1.1 STUDY OBJECTIVES  
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1 INCLUSIONS AND EXCLUSIONS
           1.3.2 MARKETS COVERED
           1.3.3 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
    1.8 RECESSION IMPACT 
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH APPROACH 
    2.2 RESEARCH METHODOLOGY DESIGN 
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 KEY DATA FROM SECONDARY SOURCES
           2.2.2 PRIMARY DATA
                    2.1.2.1 KEY DATA FROM PRIMARY SOURCES
                    2.1.2.2 INSIGHTS FROM PRIMARY EXPERTS 
    2.3 MARET SIZE ESTIMATION  
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.5 MARKET SHARE ESTIMATION 
    2.6 ASSUMPTIONS FOR THE STUDY 
    2.7 RISK ASSESSMENT 
    2.8 IMPACT OF ECONOMIC RECESSION 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
5 MARKET OVERVIEW 
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 TECHNOLOGY ANALYSIS 
           5.3.1 KEY TECHNOLOGIES
           5.3.2 COMPLEMENTARY TECHNOLOGIES
           5.3.3 ADJACENT TECHNOLOGIES
    5.4 INDUSTRY TRENDS 
    5.5 VALUE CHAIN ANALYSIS 
    5.6 SUPPLY CHAIN ANALYSIS 
    5.7 PORTER'S FIVE FORCE ANALYSIS 
    5.8 TARIFF AND REGULATORY LANDSCAPE 
           5.8.1 REGULATORY ANALYSIS
           5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION 
    5.9 PATENT ANALYSIS 
    5.10 PRICING ANALYSIS 
           5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
           5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
    5.11 KEY CONFERENCES & EVENTS DURING 2023-2024 
    5.12 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS & BUYING PROCESS
           5.12.2 BUYING CRITERIA
    5.13 HS CODES FOR PEN NEEDLES 
    5.14 ECOSYSTEM/MARKET MAP 
    5.15 ADJACENT MARKET ANALYSIS 
    5.16 UNMET NEEDS ANALYSIS/END USER EXPECTATIONS 
    5.17 AI IN PEN INJECTORS 
    5.18 CASE STUDY ANALYSIS 
6 PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION) 
    6.1 INTRODCUTION  
    6.2 STANDARD PEN NEEDLES 
    6.3 SAFETY PEN NEEDLES 
7 PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION) 
    7.1 INTRODCUTION  
    7.2 8MM 
    7.3 5MM 
    7.4 6MM 
    7.5 4MM 
    7.5 12MM 
    7.5 10MM 
8 PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 
    8.1 INTRODUCTION  
    8.2 INSULIN THERAPY 
    8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY 
    8.3 GROWTH HORMONE THERAPY 
    8.4 OSTEOPOROSIS (ABOLOPARATIDE, TERIPARATIDE THERAPY) 
    8.5 OTHER APPLICATIONS 
9 PEN NEEDLES MARKET, BY END USER, 2021-2028 (USD MILLION) 
    9.1 INTRODUCTION  
    9.2 PATIENTS/HOME CARE 
    9.3 HOSPITALS AND CLINICS 
    9.4 OTHER END USERS 
10 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION) 
     10.1 INTRODUCTION  
     10.2 PRESCRIPTION-BASED  
     10.3 OVER THE COUNTER (OTC) 
     10.4 ONLINE PURCHASE 
     10.5 OTHER MODES OF PURCHASE 
11 PEN NEEDLES MARKET, BY REGION, 2021-2028 (USD MILLION) 
     11.1 INTRODUCTION 
     11.2 NORTH AMERICA 
             11.2.1 IMPACT OF ECONOMIC RECESSION
             11.2.2 US
             11.2.3 CANADA
     11.3 EUROPE 
             11.3.1 IMPACT OF ECONOMIC RECESSION
             11.3.2 GERMANY 
             11.3.3 FRANCE
             11.3.4 UK 
             11.3.5 ITALY
             11.3.6 SPAIN
             11.3.7 REST OF EUROPE 
     11.4 ASIA PACIFIC 
             11.4.1 IMPACT OF ECONOMIC RECESSION
             11.4.2 JAPAN
             11.4.3 CHINA
             11.4.4 AUSTRALIA & NEW ZEALAND 
             11.4.5 INDIA
             11.4.6 SOUTH KOREA
             11.4.7 SOUTHEAST ASIA
             11.4.8 ROAPAC
     11.5 LATIN AMERICA 
             11.5.1 IMPACT OF ECONOMIC RECESSION
             11.5.2 BRAZIL
             11.5.3 MEXICO
             11.5.4 ARGENTINA
             11.5.5 REST OF LATIN AMERICA
     11.6 MIDDLE EAST & AFRICA 
             11.6.1 IMPACT OF ECONOMIC RECESSION 
12 COMPETITIVE LANDSCAPE 
     12.1 INTRODUCTION 
     12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 
     12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS  
     12.4 COMPANY EVALUATION MATRIX  
             12.4.1 STARS
             12.4.2 EMERGING LEADERS
             12.4.3 PERVASIVE PLAYERS
             12.4.4 PARTICIPANTS
             12.4.5 COMPANY FOOTPRINT 
     12.5 START-UP/SME EVALUATION MATRIX  
             12.5.1 PROGRESSIVE COMPANIES 
             12.5.2 RESPONSIVE COMPANIES
             12.5.3 DYNAMIC COMPANIES 
             12.5.4 STARTING BLOCKS 
             12.5.5 COMPETITIVE BENCHMARKING
     12.6 MARKET SHARE ANALYSIS 
     12.7 COMPETITIVE SITUATION AND TRENDS 
             12.7.1 PRODUCT LAUNCHES & APPROVALS
             12.7.2 DEALS
             12.7.3 OTHER DEVELOPMENTS
13 COMPANY PROFILE 
     13.1 KEY PLAYERS 
             13.1.1 EMBECTA CORP.
             13.1.2 NOVO NORDISK A/S
             13 1.3 YPSOMED HOLDING AG 
             13.1.4 B. BRAUN MELSUNGEN AG
             13.1.5 TERUMO CORPORATION
             13.1.6 NIPRO CORPORATION
             13.1.7 OWEN MUMFORD
             13.1.8 ARKRAY
             13.1.9 ULTIMED
             13.1.10 HINDUSTAN SYRINGES AND MEDICAL DEVICES
             13.1.11 MONTMED
             13.1.12 HTL-STREFA
             13.1.13 ALLISON MEDICAL, INC.
             13.1.14 GLUCORX
             13.1.15 BERPU MEDICAL TECHNOLOGY
             13.1.16 ADVACARE PHARMA 
             13.1.17 ARTSANA GROUP
             13.1.18 PROMISEMED DIABETES CARE
             13.1.19 TRIVIDIA HEALTH
             13.1.20 VOGT MEDICAL VERTRIEB
     13.2 OTHER PLAYERS 
             13.2.1 VAN HEEK MEDICAL
             13.2.2 SIMPLE DIAGNOSTICS
             13.2.3 IYON 
             13.2.4 LINKS MEDICAL PRODUCTS
             13.2.5 MHC MEDICAL PRODUCTS
14 APPENDIX 
     14.1 INSIGHTS OF INDUSTRY EXPERTS 
     14.2 DISCUSSION GUIDE 
     14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 
*Contents in the ToC/market segments are tentative and might change as the research proceeds.
*List of companies is not exhaustive and might change during course of study.
*Details on key financials might not be captured in case of unlisted companies